Marijuana

Senate Approved Funding Bill Allowing Medical Marijuana for Veterans

Just in time for Veterans Day, the Senate passed the Fiscal Year 2016 Military Construction and Veteran Affairs (MilCon-VA) Appropriations Bill, which will include a stipulation for the first time ever to allow doctors in the Veterans Administration to recommend medical marijuana to their patients in states where it is legal.

This is not the first time that Congress has tried to gain medical cannabis access for veterans. Representative Earl Blumenauer (D-OR) of the House of Representatives has introduced the Veterans Equal Access Act not once, but twice in the past two years, only for the bill to stall in the Subcommittee on Health. This time, the bipartisan amendment was introduced by Senator Jeff Merkley (D-OR) and Senator Steve Daines (R-MT) and was included in the Senate Appropriations committee this past May.

Having passed through the Senate Appropriations Committee with an 18-12 vote, the funding bill will now be included and negotiated as part of a more comprehensive omnibus spending bill to determine federal funding for the next fiscal year. A version of the Daines-Merkley amendment was included as an extension of the much-lauded CARERS Act, and although the bill has generated bipartisan interest and gained numerous sponsors from both sides of the aisle, Congress has not taken action towards passing it.

Allowing veterans access to medical marijuana has proved to be controversial in the past, despite evidence that cannabis can help alleviate many severe symptoms of Post-Traumatic Stress Disorder (PTSD), which affects nearly 31 percent of Vietnam veterans and as much as 11 percent of veterans of the Gulf War and war efforts in Afghanistan.

Veterans, we salute your service, and we are grateful to see Congress offering a token of gratitude for the soldiers who risk their lives for our peace of mind.

PopNaturals special!

Buy any 2 cartridges and get a free battery! 

(While Suplies last)

Columbia Gorge Collective

Northernberry and Big Wreck from Columbia Gorge Collective are now in! Grown locally by one of our own Gorge Greenery Girls! Both are indicas, come down and grab some while supplies last!

Grand Opening and 21+ Rec Party!

Come to our party!

Live local music and catering from Boda’s Kitchen begins at 5! Specials Include:   *sign up for our mailing list and get a free pre roll
*buy a PAX2 and get a free grinder
*drawing every half hour for hats, shirts, socks, glassware, grinders, and gift certificates
*buy 7grams and get $5 off any size CVault
Looking forward to seeing you there!
21+ and OMMP card holders welcome

Facebook Link is here –>Facebook Event and
Google+ Link is here –> Google Calendar, Gmail, Google+                                                                                                                           Find us on WordPress here!

See you then! :-)                                                                                                                            


 

National Alzheimer's Day

Today is National Alzheimer’s Day, a day dedicated to the pursuit of medical research that could one day better the lives of millions of people who are affected by this disease. Here are the top 5 ways Cannabis helps these patients.

1. THC Slows Buildup of Neural Plaques

One of the characterizing pathological markers of Alzheimer’s is the buildup of amyloid plaques, a toxic aggregation of peptides in the neural tissue. This 2008 study published in Molecular Pharmaceutics found that THC slowed this amyloid β-peptide (Aβ) overgrowth, a discovery that was again observed in a 2014 study that appeared in Journal of Alzheimer’s Disease. The earlier authors even found a low dose of THC to be “a considerably more effective inhibitor of AChE-induced Aβ deposition than the approved drugs for Alzheimer's disease treatment, donepezil and tacrine, which reduced Aβ aggregation by only 22% and 7%, respectively, at twice the concentration used in our studies.”

 

2. Cannabis Fights Inflammation

Another contributor to the development of Alzheimer’s is inflammation around these amyloid plaques. A 2006 report published in Neuroscience analyzed the role of the endocannabinoid system (ECS) in Alzheimer’s, as activation of CB1 receptor sites had an anti-inflammatory effect. Other research cited in a 2012 review reiterated its importance; one study found that mice bred without CB1 receptors experienced faster cognitive degeneration. The connection between the ECS and neurodegenerative diseases has yet to be developed in human trials, but the premise of this preliminary research alone is encouraging.

 

3. CBD Could Prevent Cell Death

THC isn’t the only compound cannabis has to offer for Alzheimer’s research; the non-psychoactive cannabidiol – better known as CBD – has also hinted at its benefits in preventing cell death. In 2004, researchers noted CBD’s neuroprotective, anti-oxidative, and anti-apoptotic properties, thus reducing neurotoxicity caused by amyloid buildup. These phenomena were again reviewed in a 2009 report that explored promising avenues in cannabinoid therapy, including that which involves a combination of THC and CBD. Noting the synergistic potential of cannabis constituents like CBD and THC, the researchers concluded with cautious optimism:

“The great therapeutic value of CBD, either given alone or in association with THC, derives from the consideration that it represents a rare, if not unique, compound that is capable of affording neuroprotection by the combination of different types of properties (e.g., anti-glutamatergic effects, anti-inflammatory action, and antioxidant effects) that almost cover all spectra of neurotoxic mechanisms that operate in neurodegenerative disorders (excitotoxicity, inflammatory events, oxidative injury, etc.).”

 

4. Cannabinoids Stimulate Cell Growth

So in addition to cannabis’ antioxidant, anti-inflammatory, and neuroprotective attributes, it would appear that cannabinoids may also play a role in the growth of neural tissue in the hippocampus – the area of the brain associated with memory. This mechanism known as “neurogenesis” was explored and discussed in a 2011 study, as well as in a 2007 report that observed cannabinoids “supporting the brain's intrinsic repair mechanisms.”

 

5. Staving Off Other Alzheimer’s Symptoms

One of the more compelling arguments for medical marijuana is its ability to alleviate other symptoms associated with Alzheimer’s, allowing patients to live happier and more functional lives. From appetite stimulation and weight control to motor functioning and agitation reduction, the improved quality of life that cannabis may offer these patients should be enough to warrant a rescheduling of these versatile cannabinoids.

Looking back at decades of research supporting cannabis’ therapeutic benefits in not only Alzheimer’s, but in cancer, pain, epilepsy, stress disorders, sleep disorders, MS, HIV/AIDS, glaucoma, fibromyalgia, gastrointestinal disorders, arthritis, anorexia, diabetes, spasticity, it’s utterly incomprehensible to see cannabis still ranked as a Schedule 1 substance among the likes of heroin.


Cheers to all of the scientists out there making this research happen despite political obstacles and pitfalls.

"Cannabis has been show to kill cancer cells in the laboratory..."

The National Cancer Institute is an organization mandated by U.S. law to educate Americans about cancer and the latest research efforts. According to its website, NCI is touted as "the U.S. government's principal agency for cancer research." And recently, it quietly admitted that cancer cells have been killed by cannabis in a lab setting. 

NCI's website has a section that provides a basic overview of what cannabis is and how cannabinoids affect the human body. Included in this section is a surprising bullet point:

"Cannabis has been show to kill cancer cells in the laboratory (see Question 6)."

"Question 6" refers to whether any preclinical studies have been conducted using either cannabis or cannabinoids. The website references studies conducted on mice and rats that allude to cannabinoids inhibiting tumor growth by causing cells to die, blocking cell growth, and blocking the development of blood vessels tumors rely on for growth. It also linked to additional studies which are summarized below: 

  • Cannabinoids can potentially reduce the risk of colon cancer due to its anti-inflammatory effects on the colon;
  • Delta-9-THC was found to damage or kill liver cancer cells;
  • Delta-9-THC had anti-tumor effects;
  • CBD caused breast cancer cell death while having little effect on normal/healthy breast cells;
  • CBD, when used with chemotherapy, may help make chemotherapy more effective and increase cancer cell death without adversely impacting normal/healthy cells.

Furthermore, NCI acknowledged that cannabis can help with the following:

  • Stimulating appetite
  • Pain relief
  • Relieving nausea/vomiting
  • Treating anxiety
  • Improving sleep quality

Despite all of this promising research, NCI clarified that the U.S. Food and Drug Administration has not approved cannabis for use in treating cancer, and only two cannabinoids (dronabinol and nabilone) are approved for treating nausea and vomiting as a result of chemotherapy treatment.